Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Vaccine

• Publication date

  2004-09-03

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.VACCINE.2004.02.040PMID 15308368
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Swine influenza

  2010influential reference
• Recombinant adenovirus encoding the HA gene from swine H3N2 influenza virus partially protects mice from challenge with heterologous virus: A/HK/1/68 (H3N2)

  2002cited by this paper
• Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24.

  2002cited by this paper
• The emergence of novel swine influenza viruses in North America.

  2002cited by this paper
• Prevalence of swine influenza virus subtypes on swine farms in the United States

  2002cited by this paper
• Immunization of pigs against influenza virus infection by DNA vaccine priming followed by killed-virus vaccine boosting.

  2001cited by this paper
• Cutting Edge: Recombinant Adenoviruses Induce CD8 T Cell Responses to an Inserted Protein Whose Expression Is Limited to Nonimmune Cells

  2001cited by this paper
• Immune responses and protection against foot-and-mouth disease virus (FMDV) challenge in swine vaccinated with adenovirus-FMDV constructs.

  2001cited by this paper
• Genetic Characterization of an H1N2 Influenza Virus Isolated from a Pig In Indiana

  2000cited by this paper
• Diagnosis of swine influenza

  2000cited by this paper
• Single inoculation of replication-defective adenovirus-vectored vaccines at birth in piglets with maternal antibodies induces high level of antibodies and protection against pseudorabies.

  2000cited by this paper
• Evolution of Swine H3N2 Influenza Viruses in the United States

  2000cited by this paper
• Adenovirus vectors for human gene therapy.

  2000cited by this paper
• Swine pathology and diagnosis

  1999cited by this paper
• Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate.

  1999cited by this paper
• Manual of Standards for Diagnostic Tests and Vaccines

  1998cited by this paper
• A simplified system for generating recombinant adenoviruses.

  1998cited by this paper
• Immunization of Pigs with a Particle-Mediated DNA Vaccine to Influenza A Virus Protects against Challenge with Homologous Virus

  1998influential reference
• Study of the delivery of the gD gene of pseudorabies virus to one-day-old piglets by adenovirus or plasmid DNA as ways to by-pass the inhibition of immune response by colostral antibodies.

  1997cited by this paper
• Manual of Standards for Diagnostic Tests and Vaccines

  1997cited by this paper
• Efficacy of replication-defective adenovirus-vectored vaccines: protection following intramuscular injection is linked to promoter efficiency in muscle representative cells.

  1997cited by this paper
• Orthomyxoviridae: The Viruses and Their Replication.

  1996cited by this paper
• Defective adenoviruses as virus vectors for veterinary vaccines.

  1995cited by this paper
• CLINICAL VIROLOGY MANUAL

  1995cited by this paper
• Immunogenicity of high expression adenovirus-hepatitis B virus recombinant vaccines in dogs.

  1994cited by this paper
• Vaccination of pigs against pseudorabies with highly attenuated vaccinia (NYVAC) recombinant viruses.

  1993cited by this paper
• Heterologous protection against influenza by injection of DNA encoding a viral protein.

  1993cited by this paper
• Vaccines : new approaches to immunological problems

  1992cited by this paper
• Adenovirus-based expression vectors and recombinant vaccines.

  1992cited by this paper
• A highly attenuated host range-restricted vaccinia virus strain, NYVAC, encoding the prM, E, and NS1 genes of Japanese encephalitis virus prevents JEV viremia in swine.

  1992cited by this paper
• Efficacy of nucleoprotein and haemagglutinin antigens expressed in fowlpox virus as vaccine for influenza in chickens.

  1991cited by this paper
• Construction of a defective adenovirus vector expressing the pseudorabies virus glycoprotein gp50 and its use as a live vaccine.

  1990cited by this paper
• Use of human adenovirus-based vectors for antigen expression in animals.

  1989cited by this paper
• Development of adenovirus vectors for the expression of heterologous genes.

  1988cited by this paper
• The Roles of Influenza Virus Haemagglutinin and Nueleoprotein in Protection: Analysis Using Vaccinia Virus Recombinants

  1987cited by this paper
• Purified influenza virus nucleoprotein protects mice from lethal infection.

  1987cited by this paper
• Identification of a 17000 molecular weight antigenic polypeptide in transmissible gastroenteritis virus-infected cells.

  1986cited by this paper
• Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes.

  1985cited by this paper
• Characteristics of a human cell line transformed by DNA from human adenovirus type 5.

  1977cited by this paper

• Swine influenza A virus: challenges and novel vaccine strategies

  2024cites this paper
• Assessment of Immune Responses to a Trivalent Pichinde Virus-Vectored Vaccine Expressing Hemagglutinin Genes from Three Co-Circulating Influenza A Virus Subtypes in Pigs

  2023cites this paper
• Current and prospective control strategies of influenza A virus in swine

  2021cites this paper
• Adenoviral vector‐based platforms for developing effective vaccines to combat respiratory viral infections

  2021cites this paper
• Influenza A Virus in Swine: Epidemiology, Challenges and Vaccination Strategies

  2020cites this paper
• Epigraph hemagglutinin vaccine induces broad cross-reactive immunity against swine H3 influenza virus

  2020cites this paper
• Next-generation influenza vaccines: opportunities and challenges

  2020cites this paper
• Adenovirus Vectors

  2020cites this paper
• Recombinant adenovirus carrying a core neutralizing epitope of porcine epidemic diarrhea virus and heat-labile enterotoxin B of Escherichia coli as a mucosal vaccine

  2020cites this paper
• Bat influenza vectored NS1-truncated live vaccine protects pigs against heterologous virus challenge

  2020cites this paper
• Adenoviral Vector-Based Vaccine Platforms for Developing the Next Generation of Influenza Vaccines

  2020cites this paper
• Rodents Versus Pig Model for Assessing the Performance of Serotype Chimeric Ad5/3 Oncolytic Adenoviruses

  2019cites this paper
• Adenoviruses

  2019cites this paper
• PREDICTION OF PEPTIDE BINDING TO SWINE LEUKOCYTE ANTIGEN ( SLA-1 ) PROTEINS BY MOLECULAR DOCKING

  2018cites this paper
• Universal Vaccines and Vaccine Platforms to Protect against Influenza Viruses in Humans and Agriculture

  2018cites this paper
• Safety profile of a replication-deficient human adenovirus-vectored foot-and-mouth disease virus serotype A24 subunit vaccine in cattle.

  2018cites this paper
• Review on Adeno Virus; As a Vaccine Vehicle

  2017cites this paper
• Virus replicon particle vaccines expressing nucleoprotein of influenza A virus mediate enhanced inflammatory responses in pigs

  2017cites this paper
• Immunogenicity of a recombinant adenovirus expressing porcine reproductive and respiratory syndrome virus polyepitopes.

  2017cites this paper
• Development of Adenovirus-vectored Prototype Vaccines for African Swine Fever Virus and Bovine Viral Diarrhea Virus

  2017cites this paper
• Adenovirus vector-based multi-epitope vaccine provides partial protection against H5, H7, and H9 avian influenza viruses

  2017cites this paper
• Vaccines and vaccination for swine influenza: differing situations in Europe and the USA

  2016cites this paper
• Conserved hemagglutinin peptides of influenza virus as potential multivalent vaccine candidate: characterization of immune response in different animal models

  2016cites this paper
• Genetically Modified Food Animals

  2016cites this paper
• Viral vector-based influenza vaccines

  2016cites this paper
• Chimpanzee adenovirus vector-based avian influenza vaccine completely protects mice against lethal challenge of H5N1.

  2016cites this paper
• Vaccines against influenza A viruses in poultry and swine: Status and future developments.

  2015cites this paper
• The epidemiology of influenza A viruses in pigs in Thailand and Cambodia

  2015cites this paper
• Progress on adenovirus-vectored universal influenza vaccines

  2015cites this paper
• Oral Fluids as a Live-Animal Sample Source for Evaluating Cross-Reactivity and Cross-Protection following Intranasal Influenza A Virus Vaccination in Pigs

  2015cites this paper
• Optimal Use of Vaccines for Control of Influenza A Virus in Swine

  2015cites this paper
• Animal Models for Influenza Viruses: Implications for Universal Vaccine Development

  2014cites this paper
• An Overview of Live Attenuated Recombinant Pseudorabies Viruses for Use as Novel Vaccines

  2014cites this paper
• Pathogenesis and vaccination of influenza A virus in swine.

  2014cites this paper
• Virus-Vectored Influenza Virus Vaccines

  2014cites this paper
• All-in-One Bacmids: an Efficient Reverse Genetics Strategy for Influenza A Virus Vaccines

  2014cites this paper
• Influenza vaccinology and clinical assessment

  2014influential citation
• Prevention and Control of Influenza Viruses

  2014cites this paper
• Development of a vectored equine herpesvirus type 1 (EHV-1) vaccine against pandemic influenza A virus (09/H1N1)

  2013cites this paper
• Recombinant equine herpesvirus 1 (EHV-1) vaccine protects pigs against challenge with influenza A(H1N1)pmd09.

  2013cites this paper
• Recombinant adenovirus expressing type Asia1 foot-and-mouth disease virus capsid proteins induces protective immunity against homologous virus challenge in mice.

  2013cites this paper
• Haemagglutinin and nucleoprotein replicon particle vaccination of swine protects against the pandemic H1N1 2009 virus

  2013cites this paper
• Development of a gold nanoparticle-based oligonucleotide microarray for simultaneous detection of seven swine viruses.

  2013cites this paper
• Immune responses and protective efficacy of a recombinant swinepox virus co-expressing HA1 genes of H3N2 and H1N1 swine influenza virus in mice and pigs.

  2013cites this paper
• Development of a vectored equine herpesvirus type 1 (EHV-1) vaccine against pandemic influenza A virus (09/H1N1)

  2013cites this paper
• Recombinant adenovirus expressing F and H fusion proteins of peste des petits ruminants virus induces both humoral and cell-mediated immune responses in goats.

  2013cites this paper
• Swine influenza virus vaccines: to change or not to change-that's the question.

  2013cites this paper
• Immune responses and protective efficacy of a recombinant swinepox virus expressing HA1 against swine H1N1 influenza virus in mice and pigs.

  2012influential citation
• Improvement of the PapMV nanoparticle adjuvant property through an increased of its avidity for the antigen [influenza NP].

  2012cites this paper
• Protection of guinea pigs by vaccination with a recombinant swinepox virus co-expressing HA1 genes of swine H1N1 and H3N2 influenza viruses

  2012cites this paper
• Report of the 5th meeting on influenza vaccines that induce broad spectrum and long-lasting immune responses, World Health Organization, Geneva, 16-17 November 2011.

  2012cites this paper
• Intranasal Vaccination with Replication-Defective Adenovirus Type 5 Encoding Influenza Virus Hemagglutinin Elicits Protective Immunity to Homologous Challenge and Partial Protection to Heterologous Challenge in Pigs

  2012cites this paper
• Studies on influenza virus replicon particle vaccines in pigs

  2012influential citation
• Immune responses and protection efficacy of a recombinant swinepox virus expressing HA1 against swine H3N2 influenza virus in mice and pigs.

  2012influential citation
• Vaccine development for protecting swine against influenza virus

  2012influential citation
• Preliminary Assessment of the Efficacy of a T-Cell–Based Influenza Vaccine, MVA-NP+M1, in Humans

  2012cites this paper
• A novel alphavirus replicon-vectored vaccine delivered by adenovirus induces sterile immunity against classical swine fever.

  2011cites this paper
• Avian CD154 enhances humoral and cellular immune responses induced by an adenovirus vector-based vaccine in chickens.

  2011cites this paper
• Protective cellular responses elicited by vaccination with influenza nucleoprotein delivered by a live recombinant attenuated Salmonella vaccine.

  2011cites this paper
• Adenovirus-vectored drug–vaccine duo as a potential driver for conferring mass protection against infectious diseases

  2011cites this paper
• Os virus da Influenza A H5N1 e H1N1: características e potencial zoonótico

  2011cites this paper
• Development of efficacious replicon particle vaccines for swine influenza virus

  2011cites this paper
• Cold-Adapted Influenza and Recombinant Adenovirus Vaccines Induce Cross-Protective Immunity against pH1N1 Challenge in Mice

  2011cites this paper
• Live attenuated swine influenza vaccine by reverse genetics

  2010cites this paper
• Avian Influenza Vaccination in Chickens and Pigs with Replication-Competent Adenovirus–Free Human Recombinant Adenovirus 5

  2010cites this paper
• Protection against multiple influenza A virus subtypes by intranasal administration of recombinant nucleoprotein

  2010cites this paper
• Production of adenovirus vectors and their use as a delivery system for influenza vaccines

  2010cites this paper
• Swine influenza vaccines: current status and future perspectives

  2010influential citation
• Enhanced immunity against classical swine fever in pigs induced by prime-boost immunization using an alphavirus replicon-vectored DNA vaccine and a recombinant adenovirus.

  2010cites this paper
• Influenza: a unique problem in vaccination

  2010cites this paper
• Animal models for the preclinical evaluation of candidate influenza vaccines

  2010cites this paper
• Replicon particle vaccine protects swine against influenza.

  2010cites this paper
• Prime-boost immunization with HA/C3d DNA followed by a recombinant pseudorabies virus boost enhanced protective immunity against H3N2 swine influenza virus in mice.

  2010cites this paper
• Generation and efficacy evaluation of a recombinant adenovirus expressing the E2 protein of classical swine fever virus.

  2010cites this paper
• Trends in development of the influenza vaccine with broader cross-protection.

  2010cites this paper
• Cross-protective immunity to influenza A viruses

  2010cites this paper
• Single mucosal immunization of recombinant adenovirus-based vaccine expressing F1 protein fragment induces protective mucosal immunity against respiratory syncytial virus infection.

  2010cites this paper
• Fusion of C3d with hemagglutinin enhances protective immunity against swine influenza virus.

  2009cites this paper
• Recombinant Vectors as Influenza Vaccines

  2009cites this paper
• Development of an Antibiotic Resistance Free Bivalent Vaccine Against Swine Brucellosis and Swine Influenza

  2009cites this paper
• STUDY TOWARD THE DEVELOPMENT OF ADVANCED INFLUENZA VACCINES

  2009cites this paper
• Immunoprophylaxis against important virus diseases of horses, farm animals and birds

  2009cites this paper
• Expression and function of DMT1 without IRE in C6 cells mediated by recombinant adenovirus

  2009cites this paper
• Intranasal administration of a recombinant adenovirus expressing the norovirus capsid protein stimulates specific humoral, mucosal, and cellular immune responses in mice.

  2008cites this paper
• Multiple alternating immunizations with DNA vaccine and replication incompetent adenovirus expressing gB of pseudorabies virus protect animals against lethal virus challenge.

  2008cites this paper
• Development of recombinant porcine parvovirus-like particles as an antigen carrier formed by the hybrid VP2 protein carrying immunoreactive epitope of porcine circovirus type 2.

  2008cites this paper
• Swine influenza virus: zoonotic potential and vaccination strategies for the control of avian and swine influenzas.

  2008cites this paper
• Over-expressed human divalent metal transporter 1 is involved in iron accumulation in MES23.5 cells.

  2008cites this paper
• Immune responses of recombinant adenovirus co-expressing VP1 of foot-and-mouth disease virus and porcine interferon alpha in mice and guinea pigs.

  2008cites this paper
• Special Topic: Progress and Challenges in Vaccinology Development of a Vaccine Against Pandemic Influenza Viruses: Current Status and Perspectives

  2008cites this paper
• Influenza vaccines and vaccination strategies in birds.

  2008cites this paper
• Level of protection of chickens against highly pathogenic H5 avian influenza virus with Newcastle disease virus based live attenuated vector vaccine depends on homology of H5 sequence between vaccine and challenge virus.

  2008cites this paper
• [Generation and immunogenicity of a recombinant adenovirus expressing the E2 protein of classical swine fever virus in rabbits].

  2008cites this paper
• Swine influenza viruses a North American perspective.

  2008cites this paper
• Failure of protection and enhanced pneumonia with a US H1N2 swine influenza virus in pigs vaccinated with an inactivated classical swine H1N1 vaccine.

  2008cites this paper
• Enhanced immunogenicity of multiple-epitopes of foot-and-mouth disease virus fused with porcine interferon alpha in mice and protective efficacy in guinea pigs and swine.

  2008cites this paper
• Human infection with highly pathogenic H5N1 influenza virus.

  2008cites this paper
• Polarization of protective immunity induced by replication-incompetent adenovirus expressing glycoproteins of pseudorabies virus

  2008cites this paper
• Partial protection against H5N1 influenza in mice with a single dose of a chimpanzee adenovirus vector expressing nucleoprotein.

  2007cites this paper
• Protection of pigs against post-weaning multisystemic wasting syndrome by a recombinant adenovirus expressing the capsid protein of porcine circovirus type 2.

  2007cites this paper